Literature DB >> 15526815

Role of KL-6 in evaluating the disease severity of rheumatoid lung disease: comparison with HRCT.

Fumiko Kinoshita1, Hidefumi Hamano, Hiromi Harada, Toshibumi Kinoshita, Tadashi Igishi, Hiroshi Hagino, Toshihide Ogawa.   

Abstract

OBJECTIVE: To determine the role of KL-6 (Krebs von den Lungen-6) in evaluating the disease severity of pulmonary lesions in rheumatoid arthritis (RA) compared with high resolution computed tomography (HRCT) findings.
METHODS: Fifty serum KL-6 levels and HRCT images were prospectively obtained from 47 RA patients. Eight HRCT findings were classified into five grades. Patients were also divided into two groups according to the KL-6 threshold level and HRCT findings were evaluated.
RESULTS: There was a positive correlation between the serum KL-6 level and the total CT score (r = 0.83). Reticular opacity most closely related to the serum KL-6 levels (r = 0.84). In the high KL-6 group (n = 10), the average CTscore was markedly increased (64.6 points) and severe honeycombing expanded into the whole lung. One case revealed diffuse ground glass opacity. In 12 of 40 cases in the normal KL-6 group, CT scores mildly increased compared with the other cases (over 20 points). The predominant finding of these cases could be classified into four types: (1) narrow spread honeycombing; (2) subtle fibrosis; (3) airway diseases; and (4) dense consolidation.
CONCLUSION: KL-6 is a useful marker to detect severe RA lung disease. It is also useful to distinguish non-fibrosis from fibrosis predominant cases. However, it sometimes could not detect early stage RA lung disease.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15526815     DOI: 10.1016/j.rmed.2004.04.003

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  17 in total

Review 1.  Comprehensive review of current diagnostic and treatment approaches to interstitial lung disease associated with rheumatoid arthritis.

Authors:  Cemal Bes
Journal:  Eur J Rheumatol       Date:  2018-07-01

2.  Interstitial lung disease in rheumatoid arthritis.

Authors:  Dana P Ascherman
Journal:  Curr Rheumatol Rep       Date:  2010-10       Impact factor: 4.592

Review 3.  Treatment of rheumatoid arthritis-associated interstitial lung disease: a perspective review.

Authors:  Kundan Iqbal; Clive Kelly
Journal:  Ther Adv Musculoskelet Dis       Date:  2015-12       Impact factor: 5.346

Review 4.  A roadmap to promote clinical and translational research in rheumatoid arthritis-associated interstitial lung disease.

Authors:  Tracy J Doyle; Joyce S Lee; Paul F Dellaripa; James A Lederer; Eric L Matteson; Aryeh Fischer; Dana P Ascherman; Marilyn K Glassberg; Jay H Ryu; Sonye K Danoff; Kevin K Brown; Harold R Collard; Ivan O Rosas
Journal:  Chest       Date:  2014-03-01       Impact factor: 9.410

5.  Biomarkers of rheumatoid arthritis-associated interstitial lung disease.

Authors:  Juan Chen; Tracy J Doyle; Yongliang Liu; Rohit Aggarwal; Xiaoping Wang; Yonghong Shi; Sheng Xiang Ge; Heqing Huang; Qingyan Lin; Wen Liu; Yongjin Cai; Diane Koontz; Carl R Fuhrman; Maria F Golzarri; Yushi Liu; Hiroto Hatabu; Mizuki Nishino; Tetsuro Araki; Paul F Dellaripa; Chester V Oddis; Ivan O Rosas; Dana P Ascherman
Journal:  Arthritis Rheumatol       Date:  2015-01       Impact factor: 10.995

6.  Malondialdehyde-Acetaldehyde Adducts and Antibody Responses in Rheumatoid Arthritis-Associated Interstitial Lung Disease.

Authors:  Bryant R England; Michael J Duryee; Punyasha Roul; Tina D Mahajan; Namrata Singh; Jill A Poole; Dana P Ascherman; Liron Caplan; M Kristen Demoruelle; Kevin D Deane; Lynell W Klassen; Geoffrey M Thiele; Ted R Mikuls
Journal:  Arthritis Rheumatol       Date:  2019-07-22       Impact factor: 10.995

7.  Sequential changes of serum KL-6 predict the progression of interstitial lung disease.

Authors:  Ying Jiang; Qun Luo; Qian Han; Junting Huang; Yonger Ou; Miao Chen; Yu Wen; Silas Sethiel Mosha; Kuimiao Deng; Rongchang Chen
Journal:  J Thorac Dis       Date:  2018-08       Impact factor: 2.895

8.  Coadministration of cyclosporin a with prednisolone in acute interstitial pneumonia complicating polymyositis/dermatomyositis.

Authors:  Yasuhiro Shimojima; Wataru Ishii; Masayuki Matsuda; Nagaaki Katoh; Ko-Ichi Tazawa; Yoshiki Sekijima; Shu-Ichi Ikeda
Journal:  Clin Med Insights Arthritis Musculoskelet Disord       Date:  2012-03-14

9.  Phenotypes of Peripheral Blood Lymphocytes and Cytokine Expression in Polymyositis and Dermatomyositis before Treatment and after Clinical Remission.

Authors:  Yasuhiro Shimojima; Wataru Ishii; Masayuki Matsuda; Shu-Ichi Ikeda
Journal:  Clin Med Insights Arthritis Musculoskelet Disord       Date:  2012-10-18

10.  Idiopathic pulmonary fibrosis: the need for early diagnosis.

Authors:  Gaetano Cicchitto; Claudio M Sanguinetti
Journal:  Multidiscip Respir Med       Date:  2013-08-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.